Format

Send to

Choose Destination
Clin Infect Dis. 2015 Aug 1;61(3):368-74. doi: 10.1093/cid/civ309. Epub 2015 Apr 21.

Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.

Author information

1
Department of Epidemiology, Gillings School of Global Public Health Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
2
Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill.
3
Department of Epidemiology, Gillings School of Global Public Health.
4
Division of Epidemiology and Biostatistics, School of Public Health, University of Witwatersrand, Parktown, South Africa.
5
Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
6
University of North Carolina, UNC Project, Lilongwe, Malawi.
7
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

Abstract

BACKGROUND:

Cotrimoxazole preventive therapy (CPT) is recommended for all human immunodeficiency virus (HIV)-exposed infants to avoid opportunistic infections. Cotrimoxazole has antimalarial effects and appears to reduce clinical malaria infections, but the impact on asymptomatic malaria infections is unknown.

METHODS:

We conducted an observational cohort study using data and dried blood spots (DBSs) from the Breastfeeding, Antiretrovirals and Nutrition study to evaluate the impact of CPT on malaria infection during peak malaria season in Lilongwe, Malawi. We compared malaria incidence 1 year before and after CPT implementation (292 and 682 CPT-unexposed and CPT-exposed infants, respectively), including only infants who remained HIV negative by 36 weeks of age. Malaria was defined as clinical, asymptomatic (using DBSs at 12, 24, and 36 weeks), or a composite outcome of clinical or asymptomatic. Linear and binomial regression with generalized estimating equations were used to estimate the association between CPT and malaria. Differences in characteristics of parasitemias and drug resistance polymorphisms by CPT status were also assessed in the asymptomatic infections.

RESULTS:

CPT was associated with a 70% (95% confidence interval, 53%-81%) relative reduction in the risk of asymptomatic infection between 6 and 36 weeks of age. CPT appeared to provide temporary protection against clinical malaria and more sustained protection against asymptomatic infections, with no difference in parasitemia characteristics.

CONCLUSIONS:

CPT appears to reduce overall malaria infections, with more prolonged impacts on asymptomatic infections. Asymptomatic infections are potentially important reservoirs for malaria transmission. Therefore, CPT prophylaxis may have important individual and public health benefits.

KEYWORDS:

HIV; antifolate resistance; cotrimoxazole; infant; malaria

PMID:
25900173
PMCID:
PMC4542924
DOI:
10.1093/cid/civ309
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center